Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile

By |2021-05-17T18:52:31+01:00November 22nd, 2018|News, Nityr|

Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA

By |2021-05-17T18:52:31+01:00November 19th, 2018|News, Nityr|

Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.

By |2021-05-17T18:52:31+01:00November 12th, 2018|News, Nityr|

Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.

By |2021-05-17T18:52:31+01:00August 29th, 2018|Generics, News|

Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.

By |2021-05-17T18:52:31+01:00August 29th, 2018|Generics, News|
Go to Top